What is CSLLY stock price today?

Visit our real-time dashboard for the current CSLLY stock price and live market data.

Is CSLLY stock going up or down today?

CSLLY stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CSLLY stock now?

The decision to buy CSLLY depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CSLLY a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CSLLY based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CSLLY stock overvalued or undervalued?

CSLLY currently trades at a P/E ratio of 11.12, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if CSLLY is fairly priced.

What is CSLLY's P/E ratio?

CSLLY has a price-to-earnings (P/E) ratio of 11.12, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is CSLLY's market cap?

CSLLY (CSL Ltd) has a market capitalization of $32.80 billion, making it a mid-cap stock.

What is CSLLY's price to book ratio?

Price-to-book ratio for CSLLY is available on our dashboard along with other valuation metrics.

Does CSLLY pay dividends?

Yes, CSLLY pays dividends with a current yield of 4.23%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is CSLLY's dividend yield?

CSLLY's dividend yield is 4.23%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is CSLLY stock a good long-term investment?

CSLLY's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CSLLY's revenue growth rate?

Revenue growth data for CSLLY is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CSLLY are available on our dashboard with complete income statement analysis.

What are the risks of investing in CSLLY?

Key risks for CSLLY include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CSLLY compare to its competitors?

Compare CSLLY to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CSLLY's performance and positioning.

What is CSLLY's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CSLLY with bull, base, and bear case scenarios.

What do analysts say about CSLLY?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CSLLY. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CSLLY's next earnings report?

CSLLY reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CSLLY - CSL Ltd

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About CSL Ltd

CSL Ltd (CSLLY) common stock

Price Chart

Loading chart...

CSLLY Key Statistics

Market Cap

$32.80B

P/E Ratio

11.12

Dividend Yield

4.23%

How CSLLY Compares to Peers

CSLLY has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CSLLY(This stock)	$32.80B	11.1	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 22, 2026 at 6:20 AM EDT

Ready to invest in CSLLY?

Commission-free trading available. Affiliate links.

Upcoming Events for CSLLY

Dashboard

Enter a ticker to analyze